FLOWSION
Flowsion, the Denmark-based developer of continuous blood glucose systems for intensive care medicine, has won a prestigious European Commission Horizon 2020 SME Instrument award.
The grant was awarded to assist in the development of an innovative automatic blood glucose control system, Glucostat, developed by Flowsion. Glucostat is expected to reduce mortality, morbidity, length of stay and treatment costs dramatically for intensive care patients compared to existing technologies.
“It’s a welcome validation of our innovative, patented technology and a confirmation that we are addressing a really significant problem with a globally-relevant market opportunity,” said Hans Jorgen Pedersen, CEO of Flowsion. “Flowsion has already performed clinical studies with the system so we now that Glucostat will fulfil the demands of the intensive care units.”
With 5-8 % success rate the European Innovation Council SME Instrument awards are exceptionally competitive, and only 3018 companies across Europe were awarded a grant until now.
“This kind of technology is really crucial for intensive care medicine, where patients’ lifes are threatened every day. Glucose control has proven to be very difficult to perform for the intensive care units in hospitals world wide, and now getting a system that automatically helps performing blood glucose control will increase survival rate and lower treatment costs at the same time” said Hans Jorgen Pedersen. “We’ve carefully studied several technologies and designed a solution that is really elegant and simple to use, but that also delivers an enormous value for patients, doctors, nurses and hospitals.”
The SME Instrument programme is designed to assist internationally-oriented SMEs in implementing high-risk and high-potential innovation ideas. It aims at supporting projects with a European dimension that lead to major changes in how business is done.
About Flowsion
Flowsion is a European medical device
company focusing exclusively on the needs of intensive care unit
patients. Flowsion will launch new projects later on with other
continuous measurement and control technologies for the ICU patients.
More information can be found at: http://flowsion.dk
View source version on businesswire.com: https://www.businesswire.com/news/home/20180419005705/en/
Contact:
Flowsion
Hans J. Pedersen
+45 4017 3150
Email: info@flowsion.dk
Website: www.flowsion.dk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CO-ZAYO-GROUP19.4.2024 09:01:30 CEST | Press release
Zayo Group Appoints New CEO of Zayo Europe
HUBHEAD18.4.2024 22:16:32 CEST | Press release
HubHead Corp. Acquires DataSeer Inc. Assets to Expand its Vertical AI Capabilities
POPULAR,-INC.18.4.2024 20:30:30 CEST | Press release
Banco Popular Launches a New Campaign 'We Follow Your Rhythm'; Introduces Audio Branding
B2BROKER18.4.2024 18:07:28 CEST | Press release
B2Broker Increases Leverage on Major FX Pairs to 1:200
OH-PROEMION-HOLDING-GMBH18.4.2024 17:33:27 CEST | Press release
Proemion Holding GmbH Agrees to Acquire TrendMiner NV to Expand Industrial Asset-Monitoring and Analytics Platform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom